Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Plos Neglected Tropical Diseases|October 23, 2008
Web-based virtual microscopy for parasitology: a novel tool for education and quality assuranceEwert Linder, Mikael Lundin, Cecilia Thors, et al.
Cancer Research|March 1, 2005
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cellsTeemu T Junttila, Maria Sundvall, Mikael Lundin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2006
Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based seriesJohan Lundin, Tiina Lehtimäki, Mikael Lundin, et al.
Molecular Cancer Research : MCR|December 26, 2006
Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomasMarjut Puputti, Olli Tynninen, Harri Sihto, et al.
Scandinavian Journal of Gastroenterology|June 21, 2006
Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumoursHarri Sihto, Kaarle Franssila, Minna Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401, Minna Tanner, Jorma Isola, et al.
Molecular Biology of the Cell|October 28, 2005
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growthJorma A Määttä, Maria Sundvall, Teemu T Junttila, et al.
Cancer Research|December 26, 2003
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridizationKarin Rennstam, Minna Ahlstedt-Soini, Bo Baldetorp, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 15, 2014
Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinomaSami K Saarelainen, Synnöve Staff, Nina Peltonen, et al.
American Journal of Clinical Pathology|July 17, 2009
Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteriaYun Gong, William Sweet, Yi-Jing Duh, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Plos Neglected Tropical Diseases|October 23, 2008
Web-based virtual microscopy for parasitology: a novel tool for education and quality assuranceEwert Linder, Mikael Lundin, Cecilia Thors, et al.
Cancer Research|March 1, 2005
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cellsTeemu T Junttila, Maria Sundvall, Mikael Lundin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2006
Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based seriesJohan Lundin, Tiina Lehtimäki, Mikael Lundin, et al.
Molecular Cancer Research : MCR|December 26, 2006
Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomasMarjut Puputti, Olli Tynninen, Harri Sihto, et al.
Scandinavian Journal of Gastroenterology|June 21, 2006
Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumoursHarri Sihto, Kaarle Franssila, Minna Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401, Minna Tanner, Jorma Isola, et al.
Molecular Biology of the Cell|October 28, 2005
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growthJorma A Määttä, Maria Sundvall, Teemu T Junttila, et al.
Cancer Research|December 26, 2003
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridizationKarin Rennstam, Minna Ahlstedt-Soini, Bo Baldetorp, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 15, 2014
Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinomaSami K Saarelainen, Synnöve Staff, Nina Peltonen, et al.
American Journal of Clinical Pathology|July 17, 2009
Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteriaYun Gong, William Sweet, Yi-Jing Duh, et al.
Pageof 15